Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05317312 · ClinicalTrials.gov registry record · Phase 2
Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.
A Phase 2 study of Pain and Postoperative Pain, sponsored by Mylan Specialty.
- Completed
- Registry status
- Phase 2
- Development phase
- 111
- Enrollment target
- 1
- Study location
NCT05317312: Completed Phase 2 study of Pain and Postoperative Pain, sponsored by Mylan Specialty.
NCT05317312 is a Phase 2 study of Pain and Postoperative Pain that has completed, run by Mylan Specialty. The registered enrollment target is 111 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05317312, a Phase 2 study of Pain and Postoperative Pain, has completed, sponsored by Mylan Specialty.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 111 participants
- Enrollment target
- 1
- Study location
Study Summary
MR-107A-02 is being studied to investigate its efficacy, safety and dose-response after dental surgery.
Primary Outcome
Participants assessed Pain Intensity (PI) using a 0-10 numeric pain rating scale (NPRS) where 0 is no pain and 10 is worst pain imaginable. PI was assessed 18 times within 24 hours after the first study dose, and immediately before any rescue medication and/or at early termination. The participant's baseline PI was subtracted from the timepoint PI, to derive a Pain Intensity Difference (PID) for each timepoint. Overall Summed Pain Intensity Difference (SPID) measures pain intensity change relati
Conditions Studied
Interventions
- DRUG Placebo
- DRUG MR-107A-02
Study Locations (1)
Utah
- Research Facility 201 - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2022-03-31 |
| Est. Completion | 2022-06-20 |
| Phase | Phase 2 |
What the finished NCT05317312 record still lists
NCT05317312 is an interventional study that assigns participants to a tested intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (63% lower).
The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05317312 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT05317312 about?
NCT05317312 is a clinical study titled "Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.". MR-107A-02 is being studied to investigate its efficacy, safety and dose-response after dental surgery.
What is the current status of trial NCT05317312?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 111 participants. The study started on 2022-03-31. Estimated completion is 2022-06-20.
What conditions does trial NCT05317312 study?
This clinical trial studies the following conditions: Pain, Postoperative Pain, Acute Pain.
What interventions are being tested in trial NCT05317312?
The interventions under investigation include: Placebo (DRUG), MR-107A-02 (DRUG).
Who is sponsoring clinical trial NCT05317312?
This trial is sponsored by Mylan Specialty, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05317312 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05317312's enrollment target sits among peer trials
111 152nd of 374 higher than 222 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
RECRUITING · Phase 2
-
Neural Correlates of Hypoalgesia Driven by Observation
RECRUITING · Phase 2
-
Cannabis for Palliative Care in Cancer
RECRUITING · Phase 2
-
Pain After Buffered Vs Non Buffered Articaine
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI